Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2006-03-28
2006-03-28
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S687000
Reexamination Certificate
active
07019035
ABSTRACT:
A method for attenuating free radical formation resulting from a bodily insult includes the step of administering bicarbonate to the body of a subject. The bicarbonate is administered at a dosage of at least 1.5 mEq/kg of body weight within a 24-hour period.
REFERENCES:
patent: 3993750 (1976-11-01), Fox, Jr.
patent: 4101647 (1978-07-01), Clauss et al.
patent: 4289750 (1981-09-01), Kopp et al.
patent: 4308255 (1981-12-01), Raj et al.
patent: 4405596 (1983-09-01), Helbig et al.
patent: 4451454 (1984-05-01), Wong
patent: 4663166 (1987-05-01), Veech
patent: 4900540 (1990-02-01), Ryan et al.
patent: 5112622 (1992-05-01), Kopp
patent: 5141739 (1992-08-01), Jung et al.
patent: 5147631 (1992-09-01), Glajch et al.
patent: 5154914 (1992-10-01), Elgavish et al.
patent: 5171563 (1992-12-01), Abrams et al.
patent: 5174987 (1992-12-01), Takaichi et al.
patent: 5210098 (1993-05-01), Nath
patent: 5232685 (1993-08-01), Speck et al.
patent: 5352435 (1994-10-01), Unger
patent: 5368840 (1994-11-01), Unger
patent: 5772984 (1998-06-01), Berg et al.
patent: 5891466 (1999-04-01), Yesair
patent: 6420436 (2002-07-01), Kirkland
patent: 6475529 (2002-11-01), Duponchelle et al.
patent: 6537272 (2003-03-01), Christopherson et al.
patent: 6627393 (2003-09-01), Segall et al.
patent: 2002/0077579 (2002-06-01), Tobe
patent: 2002/0137803 (2002-09-01), Kirkland
patent: 2003/0053953 (2003-03-01), Unger
patent: 2003/0118547 (2003-06-01), Vandenberg
patent: 2003/0180390 (2003-09-01), Keum et al.
patent: 2003/0216722 (2003-11-01), Swamson
Winaver et al, Impaired renal acidification following acute renal ischemia, Kidney International, 1986, vol. 30 No. 6, 906-13.
Rodriguez et al, Amelioration of renal ischemia injury by phosphocreatine, J. of Surgical Research, 1991, vol. 51 No. 4, 271-4.
Critical Care Medicine, vol. 32, No. 3, p. 858, “Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock”, 2004.
Nephrol Dial Transplant, vol. 9, Suppl. 4, p. 179, “Risk factors influencing survival in ICU acute renal failure”, 1994.
Journal of the American Society of Nephrology, vol. 15, No. 6, p. 1597, “Minimal Changes of Serum Creatinine Predict Prognosis in Patients after Cardiothoracic Surgery: A Prospective Cohort Study”, 2004.
Journal of the American Society of Nephrology, vol. 9, No. 4, p. 710, “Hospital-Acquired Acute Renal Failure”, 1998.
Critical Care Medicine, vol. 19, No. 11, p. 1352 “Effects of Bicarbonate therapy on hemodynamics and tissue oxygenation in pateints with lactic acidosis: A prospective, controlled clinical study” 1991.
Annals of Internal Medicine, vol. 112, p. 492, “Bicarbonate Does Not Improve Hemodynamics in Critically III Patients Who Have Lactic Acidosis”, 1990.
“Acidosis and Sodium Bicarbonate Therapy”, Dr. James Cooper, www.nda.ox.ac.uk/wfsa/d1/html/papers/pap008.htm, Published prior to Apr. 2004.
MD Scientific LLC
Pryor Alton
Schwartz Law Firm P.C.
LandOfFree
Method for attenuating free radical formation resulting from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for attenuating free radical formation resulting from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for attenuating free radical formation resulting from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3587762